Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing netilmicin (medicinal product) |
Is a |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Paromomycin |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing streptomycin (medicinal product) |
Is a |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing amikacin (medicinal product) |
Is a |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing gentamicin (medicinal product) |
Is a |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing kanamycin (medicinal product) |
Is a |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing neomycin (medicinal product) |
Is a |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing tobramycin (medicinal product) |
Is a |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Butirosin |
Is a |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing apramycin (medicinal product) |
Is a |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Sisomicin |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Amikacin sulfate |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Gentamicin sulfate |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Neomycin (substance) |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Tobramycin (substance) |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Apramycin (substance) |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
forgiftning med aminoglycosider |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
1 |
Gentamicin poisoning |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Accidental gentamicin poisoning |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Intentional gentamicin poisoning |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
forgiftning med gentamicin, uvist med hvilken hensigt |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Allergy to aminoglycoside |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Allergy to gentamicin (finding) |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
overdosis af aminoglykosider |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
1 |
Gentamicin overdose |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Accidental gentamicin overdose |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Intentional gentamicin overdose |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
overdosis af gentamicin, uvist med hvilken hensigt |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Netilmicin (substance) |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Streptomycin (substance) |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Amikacin (substance) |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Kanamycin (substance) |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing aminoglycoside (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 40 mg/1 ml injektionsvæske, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 50 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 60 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 60 mg/ml injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 80 mg/ml injektionsvæske, opløsning, ampul a 1,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 5 mg/1 ml intratekal injektionsvæske, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 10 mg/2 ml injektionsvæske til børn |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 10 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 1 g pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 800 µg/ml infusionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 80 mg/2 ml injektionsvæske, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 40 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing gentamicin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin til topikal anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicinkugleprodukt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing gentamicin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Aminoglycosides [respiratory use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Gentamicin [infections] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Gentamicin [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Gentamicin [ear] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Gentamicin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing paromomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing precisely paromomycin (as paromomycin sulfate) 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 70 mg/100 ml infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 90 mg/100 ml infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 10 mg/ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Gentamicin 240mg/6mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 240 mg/6 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Product containing dihydrostreptomycin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
dihydrostreptomycinsulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
dihydrostreptomycinsulfat 200 mg pulver til injektionsvæske, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicinsulfat 0,3 % opløsning til oftalmisk anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Lincomycin (substance) |
Is a |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Clindamycin (substance) |
Is a |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Spectinomycin (substance) |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 1,6 mg/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 2,4 mg/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
gentamicin 3,6 mg/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
isoton gentamicinsulfat 1,6 mg/ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
isoton gentamicinsulfat 2,4 mg/ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Gentamicin (substance) |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
[X]Aminoglycosides causing adverse effects in therapeutic use |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Aminoglycosides adverse reaction (disorder) |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
1 |
Allergy to aminoglycoside |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
1 |
Nephropathy induced by aminoglycoside |
Causative agent |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
1 |
Dihydrostreptomycin |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Plazomicin (substance) |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Isepamicin (substance) |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Tobramycin sulfate |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Framycetin |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Kanamycin sulfate |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Arbekacin (substance) |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Neomycin sulfate |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Neomycin C |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Neomycin palmitate |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Neomycin undecylenate |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Framycetin sulfate |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Dihydrostreptomycin sulfate |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Netilmicin sulfate (substance) |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Apramycin sulfate |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Spectinomycin hydrochloride |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Streptomycin sulfate (substance) |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Medicinal product containing aminoglycoside and acting as antibacterial agent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
1 |
Amikacin liposome |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Aminoglycoside measurement |
Component |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
1 |
Amfomycin |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|
Paromomycin sulfate |
Is a |
True |
Substance with aminoglycoside structure and antibacterial mechanism of action (substance) |
Inferred relationship |
Some |
|